A prescription form of THC significantly reduced recurring nightmares among people with post-traumatic stress disorder in a new randomized clinical trial.
For people living with post-traumatic stress disorder, sleep may not provide an escape from traumatic memories. Instead, nightmares can force them to relive frightening experiences repeatedly, often causing them to wake in panic.
New research from Charité–Universitätsmedizin Berlin suggests that a carefully controlled, cannabis-derived medication could offer relief for some patients experiencing frequent and severe PTSD-related nightmares.
The study, published in Nature Medicine, examined dronabinol—a prescription medication containing tetrahydrocannabinol, better known as THC.
The researchers tested measured doses of prescription THC drops. The study did not examine smoking cannabis, recreational marijuana or unregulated cannabis products.
More Than 170 PTSD Patients Participated
More than 170 patients diagnosed with PTSD and suffering from frequent, intense nightmares participated in the ten-week trial.
Every evening before bedtime, participants received either dronabinol drops or an identical-looking, cannabis-flavoured placebo. Neither the patients nor their medical providers knew who was receiving the active medication.
This double-blind, placebo-controlled design is considered one of the most reliable methods for determining whether a treatment actually works.
Nightmare Burden Fell More With Dronabinol
At the end of the study, patients receiving dronabinol experienced a greater reduction in nightmares than those receiving the placebo.
- Nightmare burden fell by an average of 3.7 points in the dronabinol group.
- The placebo group experienced an average reduction of 2.2 points.
- More than one-third of patients taking dronabinol reported experiencing no nightmares after ten weeks.
- Another 21% said their nightmare burden had been reduced by at least half.
Researchers also reported that approximately five out of every six patients in the dronabinol group felt that their health had noticeably improved.
How Could THC Affect Nightmares?
THC interacts with the body's endocannabinoid system, which plays a role in sleep, stress responses and the processing of emotional memories.
The researchers believe THC may reduce dream activity during rapid eye movement, or REM, sleep. REM is the stage during which vivid dreams commonly occur and the brain processes emotional experiences.
By reducing dream intensity or activity, dronabinol may help interrupt the cycle of reliving traumatic events during sleep.
It Did Not Treat Every PTSD Symptom
Although the results are encouraging, dronabinol did not significantly improve the overall severity of PTSD or accompanying depression.
Its effect appeared to be more specific to nightmares and sleep. This means it should not be described as a complete treatment or cure for PTSD.
Trauma-focused psychotherapy and other medically recommended treatments remain essential. Dronabinol may eventually become an additional option for patients whose nightmares do not respond adequately to existing care.
What About Side Effects and Dependence?
No severe side effects were reported during the study. However, mild or moderate effects—including dizziness, headaches and increased appetite—were more common among patients receiving dronabinol.
Researchers did not observe withdrawal symptoms when the medication was discontinued after the treatment period.
That does not establish that long-term use is risk-free. Future studies will need to determine whether the benefits continue, whether tolerance develops and whether extended treatment creates additional safety concerns.
A Promising but Carefully Defined Result
The study provides some of the strongest clinical evidence so far that a standardized cannabinoid medication may help address one of the most distressing symptoms of PTSD.
However, the result should not be interpreted as proof that cannabis generally treats PTSD. The researchers studied a specific prescription product, administered in controlled doses and monitored by medical professionals.
For patients repeatedly awakened by traumatic nightmares, even a treatment targeting sleep alone could meaningfully improve daily functioning and quality of life. Larger and longer studies will now be required before dronabinol could become a widely accepted treatment for PTSD-related nightmares.
Research references
Medical Xpress: Cannabis-derived THC shows promise for treating PTSD-related nightmares
Scientific study: Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial , published in Nature Medicine.
Disclaimer: This article is provided for educational and informational purposes only and should not be considered medical advice.
.jpg)
0 Comments
Hi write down your query.